Fast Facts from Thought Leader Select—Trends in HIV Reimbursement and Regulatory Involvement

September 14, 2010 · Leave a comment

Health care systems across the globe rely on the advice and counsel of health care professionals (HCPs) when making decisions on new therapies to approve appropriate levels of reimbursement for various pharmaceutical products. These regulatory and reimbursement advisers have various backgrounds, including health outcomes and economics, clinical pharmacy and medicine.

Within each medical discipline, certain physicians regularly advise government regulatory agencies and public and private insurers on which therapies meet unmet medical demands and have the lowest risk for adverse reactions as well as provide input into reimbursement considerations. Each key opinion leader (KOL) assessment conducted by Thought Leader Select includes an examination of KOL engagement in regulatory and reimbursement activities.

In an ongoing assessment of nearly more than 150 HIV key opinion leaders across the globe, Thought Leader Select has analyzed their participation in regulatory and reimbursement activities. Using keywords to link these KOLs with such activities, Thought Leader Select found that 33% of physicians regularly provide input into regulatory and reimbursement decisions. The 53 KOLs with regulatory and reimbursement involvement are split nearly in half according to their participation in general or HIV-related activities (see Chart 1). However, the majority of Thought Leaders studied are involved in public reimbursement efforts (see Chart 2). Common regulatory and reimbursement groups among studied ... read more »

TAGS: Agence Francaise de Securite des Produits de Sante  Brazilian Ministry of Health  British National Formulary  clinical pharmacy  European Medicines Agency  Food and Drug Administration  HCPs  health care professionals  health economics  health outcomes  healthcare  HIV/AIDS  HIV/AIDs specialists  Italian Medicines Agency  key opinion leaders  KOL engagement  KOL identification  KOL profiling  KOLs  London Consortium  medicine  pharmaceuticals  physicians  prescription reimbursement  private health insurance  public health insurance  regulatory agencies  Spanish Ministry of Health and Consumption  Swedish Medical Products Agency  Thought Leader Select  thought leaders

Thought Leader Select delivers KOL identification research to five leading pharma companies in the U.S. and Canada

April 14, 2010 · Leave a comment

April 15, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina-based firm dedicated to delivering solutions for key opinion leader (KOL) management for the biopharmaceutical industry, has announced the delivery of KOL identification projects for five leading North American pharmaceutical companies during the first quarter of 2010.

Five of the world’s largest pharmaceutical concerns contracted with Thought Leader Select in late 2009 to take advantage of the firm’s industry-leading deep profiling methodology for researching the skills and experiences of physician key opinion leaders across multiple therapeutic areas and disease states.  Each company had specialized needs for initiation and redevelopment of their respective rosters of key opinion leaders to assist them in a variety of deployment needs.

Thought Leader Select assisted a Canadian firm with the identification of physician key opinion leaders who specialize in influenza vaccines. The company plans to build a firm roster of KOLs in advance of a new influenza vaccine product launch.

A U.S. firm contracted Thought Leader Select to identify nurse practitioners and physician assistants, also known as non-traditional KOLs, in the therapeutic areas of gastroenterology, hepatology, and HIV/AIDS treatment, in order to better understand patient needs in these areas and gain scientific and clinical insights for new compounds.

Thought Leader Select identified Canadian physician key opinion leaders for another Canadian company, with emphasis on KOLs who specialize in heart ... read more »

TAGS: biotechnology  cardiology  clinical investigators  deep-profiling  disease states  gastroenterology  general surgery  heart failure  hemophilia  hepatology  HIV/AIDS  hypertension  influenza vaccines  key opinion leader  KOL identification  KOL management  KOL research  Kristen Smithwick  new compounds  non-traditional key opinion leaders  nurse practitioners  ortho-spine surgery  orthopaedic surgery  pharmaceutical  physician assistants  physicians  post-MI congestive heart failure  therapeutic areas  Thought Leader Select